- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Stock Screener
Use Investing.com's Stock Screener to search and filter stocks easily by multiple filters such as stock price, market cap, dividend yield and more.
196 Stocks Found
196 results
Popular Screens
Momentum Masters
+44.9%High Beta Stocks
+43.7%Technical Titans
+42.6%High Beta Bulls
+39.7%Bullish Stocks
+32.8%Fit Value Plays
+32.6%Growth Rockets
+29.7%Materials Momentum
+28.8%Small-Cap Growth Rockets
+27.1%Near 52-Week High
+26.9%Currency in GBP
Overview
Insights
Valuation
Returns
Technical
Financials
Growth
Risk
Custom
Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie Inc | London | Healthcare | Pharmaceuticals | £251.83B | 82x | -3.12 | GBX 16,552.04 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novo Nordisk L | London | Healthcare | Pharmaceuticals | £226.30B | 18.8x | 1.03 | GBX 5,167.25 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Roche Holding | London | Healthcare | Pharmaceuticals | £191.59B | 26.4x | -0.89 | GBX 25,548.55 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Roche Holding Participation | London | Healthcare | Pharmaceuticals | £191.59B | 26.4x | -0.88 | GBX 23,930.85 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novartis | London | Healthcare | Pharmaceuticals | £175.29B | 18.8x | -1.36 | GBX 9,035.89 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Abbott Laboratories L | London | Healthcare | Healthcare Equipment & Supplies | £170.17B | 17.1x | 0.12 | GBX 9,771.85 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| AstraZeneca | London | Healthcare | Pharmaceuticals | £162.05B | 28.8x | 1.24 | GBX 10,450 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.1% Upside | Upgrade to Pro+ | |
| Merck & Co Inc | London | Healthcare | Pharmaceuticals | £155.08B | 12.1x | 0.02 | GBX 6,151.53 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Gilead Sciences | London | Healthcare | Pharmaceuticals | £101.04B | 24x | 0.02 | GBX 8,275.63 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Essilor International | London | Healthcare | Healthcare Equipment & Supplies | £96.79B | 46.6x | 48.19 | GBX 21,011.52 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sanofi L | London | Healthcare | Pharmaceuticals | £87.59B | 16.7x | 0.41 | GBX 7,183.66 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK plc | London | Healthcare | Pharmaceuticals | £56.99B | 18.3x | -0.6 | GBX 1,408.50 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.2% Upside | Upgrade to Pro+ | |
| Siemens Healthineers | London | Healthcare | Healthcare Equipment & Supplies | £44.47B | 26.4x | 1.73 | GBX 4,019.59 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Merck KGaA | London | Healthcare | Pharmaceuticals | £42.46B | 17.4x | 5 | GBX 9,750.24 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Lonza Group | London | Healthcare | Biotechnology & Medical Research | £37.04B | 58x | GBX 52,305.72 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
| HALEON | London | Healthcare | Pharmaceuticals | £33.01B | 23.7x | 0.59 | GBX 367.40 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.3% Upside | Upgrade to Pro+ | |
| IDEXX Laboratories | London | Healthcare | Healthcare Equipment & Supplies | £31.78B | 48.7x | 10.02 | GBX 39,261.45 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| UCB L | London | Healthcare | Pharmaceuticals | £28.13B | 30.4x | 0.14 | GBX 14,794.22 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| arGEN X BV | London | Healthcare | Biotechnology & Medical Research | £25.47B | 31.7x | 0.08 | GBX 40,970.94 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Bayer L | London | Healthcare | Pharmaceuticals | £23.26B | -8.3x | 1.8 | GBX 2,367.42 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Humana | London | Healthcare | Healthcare Providers & Services | £20.63B | 16.3x | -1.32 | GBX 16,938 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Fresenius SE Co KGaA | London | Healthcare | Healthcare Providers & Services | £20.45B | 55.9x | 0.12 | GBX 3,639.46 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sandoz | London | Healthcare | Pharmaceuticals | £17.87B | GBX 4,141.88 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
| Koninklijke Philips | London | Healthcare | Healthcare Equipment & Supplies | £16.88B | 80.3x | 0.56 | GBX 1,782.93 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Coloplast AS | London | Healthcare | Healthcare Equipment & Supplies | £15.68B | 29.9x | -2.96 | GBX 6,993.34 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Biogen | London | Healthcare | Pharmaceuticals | £14.57B | 13.3x | 0.5 | GBX 9,873.71 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Sonova Holding | London | Healthcare | Healthcare Equipment & Supplies | £12.86B | 25.6x | -2.58 | GBX 21,862.23 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Fresenius Medical Care | London | Healthcare | Healthcare Providers & Services | £11.75B | 21.9x | 0.79 | GBX 3,998.81 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cooper Companies | London | Healthcare | Healthcare Equipment & Supplies | £11.05B | 36.1x | 1.65 | GBX 5,561.79 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Align Tech | London | Healthcare | Healthcare Equipment & Supplies | £10.86B | 36.7x | -3.83 | GBX 14,932.44 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |
Currency in GBP
- Previous
- 1
- 2
- 3
- ...
- 7
- Next
30 Rows
All Sectors
Healthcare Industries
Frequently Asked Questions
How can I build my own stock screen?
Navigate through the screener filters categories such as price, valuation, insights, financials, and more. Add relevant filters that match your investing strategy, such as P/E ratio, Market Cap, Fair Value Upside, and Financial Health Score. You will notice that each time you add a filter, the applied filters count will increase. Once you're done, click on the "Applied Filters" button to review your selected filters and view the results at the bottom of the screen.
How do I use a stock screener?
Using the stock screener is simple. You can start by choosing predefined screens like "Talk of the Town" "High Beta Bulls" "Cash is King" or "Piotroski's Picks" These screens have pre-set filters to help you quickly find stocks of interest.
For more advanced users who want to refine their search further, you can select your own filters, such as market cap, industry, or financial ratios, to match your specific investment criteria. Apply the filters to generate a list of stocks that meet your criteria. You can sort and analyse the results using different views to make informed investment decisions.
How can I save my own custom screens?
After creating a custom screen, click the "Save" button. You will be prompted to name your screen for easy reference. Saved screens can be accessed anytime from the "My Screens" button, which is located on the stock screener page next to the save button.
How can I add a stock from the screen results to my watchlist?
To add a stock to your watchlist, click on the checkbox next to the stock ticker from the screening results, and then click the "Add to Watchlist'' button.
If you have more than one watchlist, you will need to choose the relevant watchlist to add the stock to. Your watchlist can be accessed anytime through our website or app by navigating to the "Watchlist" section.
What does every filter mean? Is there a place I can see each filter definition?
Each filter in the stock screener has a tooltip explanation. Hover over the filter name with your mouse to see a brief definition of what the filter represents.
Why can’t I see local stocks from my country when choosing a predefined screen?
If you can't see local stocks from your country when choosing a predefined screen, it's likely because the criteria set in the predefined screen do not result in enough stocks from your local market. In such cases, we expand the search to include other markets to provide you with more investment options. You can always adjust the criteria yourself to focus on finding relevant stocks in your country.
Why are some filters locked?
Some filters are designated as premium features and require a Pro+ subscription to access. These filters provide advanced screening capabilities and data insights.
How do I subscribe in order to see the premium filters on my account?
To access premium filters, you can subscribe to our InvestingPro service. Visit our InvestingPro page or click on any locked filter, which will prompt you to upgrade your subscription to Pro+ plan.
What do “Views” refer to on the stock screen results?
“Views” refer to different ways of displaying the screening results. For example, you can view stocks based on fundamentals, technicals, valuation, or custom metrics. Each view highlights different aspects of the stock data to help you analyse and compare results effectively.
How can I create my own custom view of the stocks’ search results?
To create a custom view, click on the "Custom" view button. Then, choose the metrics that are important to you based on your investment strategy and how you conduct your due diligence. Save your custom view for quick access in future screenings.
How do I export my stock screener results to a CSV file?
You can export the results of your stock screener by clicking the "Download" button. Choose the CSV format and download the file to your device.
How can I download all data if I have more than 100 lines?
Our data providers do not allow exports on such a large scale. To download your data, please narrow down your results to fewer than 100 lines and then export.
What markets are covered with the stock screener?
The stock screener covers over 160,000 stocks from global markets, including North America, Europe, Asia, Latin America, and Africa. We aim to provide comprehensive coverage across major and emerging markets, covering 99% of the world's market capital.
How frequently is the data on the stock screener updated? Specifically after earning reports?
The data on the stock screener is updated constantly. Earnings report data is reflected as soon as we receive it from our data providers. High-priority companies (approximately 15,000) will have updates within 24-48 hours, while others may take up to a week.
Do the screener results also take into account premarket and after-market data?
Currently, the screener does not account for premarket and after-market data. However, this feature is on our roadmap and will be available in future updates.
Can I share my custom screens with others?
Yes, you can share your custom screens with others. Every change you make on the stock screener is reflected in the URL. Simply share the URL with anyone you wish, and they will be able to view your custom screen.
What does the Primary Listing toggle mean?
A company may have its stock listed on numerous stock exchanges around the world. The primary listing is typically the most prominent exchange and often the first exchange where the stock was listed. Secondary listings, on the other hand, are additional listings that make it more convenient for local investors to buy and sell the stock without converting currency.
The unique but secondary listings may cause you to see the same company listed multiple times in your results. To remove these secondary listings, you can use the “Primary Listing” toggle. When this filter is active only the primary stock listing of a company is included in the results, eliminating duplicates from secondary exchanges.
How can I change the currency of stock prices?
The prices displayed are attached to the currency in which the stock is traded. To view stocks in a different currency, change the country in the screener dropdown to see stocks listed in the corresponding local currency.
How can I set a stock price alert for a stock in the screener results?
To set a stock price alert, click on the checkbox next to the stock ticker from the screening results and select "Set Alert." Define the criteria for the alert, such as price threshold, percentage change, volume, or earnings. You can also choose the frequency of the alerts. Save your settings, and you will receive notifications based on your alert preferences.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.